Schizophrenia :: Eli Lilly’s schizophrenia drug Zyprexa and New York Times Article
Eli Lilly and Company (NYSE: LLY) believes it is inaccurate to imply that any single factor — including medication — was the cause of the unfortunate death of the patient profiled in New York Times – Jan_4.